Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers.

Curr Oncol · 2023 · PMC9955173 · PMID 36826142

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

did not reach statistical significanceno p-value reported

The POSEIDON trial showed that Durvalumab plus chemotherapy significantly improved PFS while a positive trend for OS did not reach statistical significance.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.